Workflow
Globenewswire
icon
搜索文档
Kiniero Grade Control Drilling Continues To Return High-Grade Gold Results
Globenewswire· 2025-07-10 18:54
公司概况 - 西非黄金生产商和开发商Robex Resources Inc报告几内亚Kiniero黄金项目Mansounia品位控制钻探结果,有望在2025年第四季度产出首批黄金 [1] 钻探成果 - 钻探显示高品位黄金,如MGC25 - 10036孔19米处金品位2.10克/吨等,增强了Mansounia矿区开采信心 [3] - 正在进行预生产品位控制钻探计划,设计1605个倾斜品位控制钻孔,已完成61700米,后续结果将陆续公布 [4][6] - 已收到的化验结果与Mansounia资源块模型预期基本一致,矿化带品位和空间分布与模型高度相关 [9] 设施协议更新 - 2025年7月9日公司与Sprott修订1.3亿美元融资协议,释放2500万美元用于Kiniero项目建设,利于几内亚业务发展
Parsons Celebrates Infrastructure Excellence in Missouri with Award on I-270 Project
Globenewswire· 2025-07-10 18:25
CHANTILLY, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) is proud to announce that its role as lead designer for the I-270 North Design-Build Project has been honored with the prestigious Engineering Excellence Award by the American Council of Engineering Companies (ACEC) of Missouri. In addition to this top state honor, the project also received national recognition through the 2025 ACEC Engineering Excellence Awards, underscoring its significance as one of the country's most innov ...
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
Globenewswire· 2025-07-10 18:21
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced the pricing of its upsized public offering of 2,058,824 shares of its common stock at a public offering price of $85.00 per share. In addition, Rhythm also granted the underwriters a 30-day option to purchase up to an additional 308,823 shares of common s ...
Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025
Globenewswire· 2025-07-10 18:00
REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today certain preliminary unaudited financial and operational results for the three months ended June 30, 2025: Soleno expects its net revenue from the sales of VYKATTM XR, for the three months ended June 30, 2025 to be between $31.0 million and $33.0 million. Soleno has determined net revenue for VY ...
Osisko Metals Infill and Expansion Drilling Intersects New Wide Mineralization at Gaspé Copper
Globenewswire· 2025-07-10 18:00
文章核心观点 公司公布Gaspé铜项目新钻探结果,显示该项目矿化具有大规模潜力,新增第九台钻机加速项目推进,结果将用于资源模型更新和升级[2][3] 项目概况 - 公司为加拿大勘探开发公司,专注铜锌关键金属领域,2023年7月收购Gaspé铜矿100%权益,目前专注该项目资源扩张,同时推进Pine Point项目[24] - Gaspé铜矿位于魁北克省Gaspé半岛,拥有指示性矿产资源8.24亿吨,平均铜当量品位0.34%,推断性矿产资源6.70亿吨,平均铜当量品位0.38%[24] - Pine Point项目位于西北地区,指示性矿产资源4950万吨,平均锌当量品位5.52%,推断性矿产资源830万吨,平均锌当量品位5.64%[26] 钻探结果 整体情况 - 新分析结果含8个钻孔的25个矿化截距,加密截距用于升级推断性矿产资源类别,扩展截距或带来额外资源[3] 重点钻孔 - 30 - 1090号钻孔:位于2024年资源模型以南105米,279米平均含铜0.49%、银3.35克/吨,108米平均含铜0.84%、银7.79克/吨,将矿化延伸至垂直深度525米[9] - 30 - 1078号钻孔:位于中南部矿床,256.5米平均含铜0.25%、银1.79克/吨,381米平均含铜0.22%、银1.69克/吨,将矿化延伸至垂直深度688米[10] - 30 - 1079号钻孔:位于中南部矿床,319.5米平均含铜0.28%、银2.14克/吨,180米平均含铜0.37%、银2.54克/吨,将矿化延伸至垂直深度636米[11] - 30 - 1081号钻孔:位于中南部矿床,301.8米平均含铜0.41%、银3.36克/吨,44.5米平均含铜0.23%、银1.32克/吨,将矿化延伸至垂直深度490米[12] - 30 - 1084号钻孔:位于矿床中南部,471.4米平均含铜0.25%、银1.95克/吨,55.4米平均含铜0.33%、银2.64克/吨,89.7米平均含铜0.29%、银1.93克/吨,将矿化延伸至垂直深度706米[13] - 30 - 1080号钻孔:位于矿床西北端,520.5米平均含铜0.23%、银1.02克/吨,195米平均含铜0.26%、银1.28克/吨,将矿化延伸至垂直深度969米[14] 矿化特征 - 矿化以黄铜矿浸染状和细脉状出现,在Needle Mountain、Needle East和Copper Brook地区受地层控制,C区和E区矽卡岩局部钼品位高,Copper Mountain至少有五次矿化事件[15] 项目进展 - 2022 - 2024年钻探聚焦Copper Mountain露天矿资源定义,向南扩展资源模型使资源显著增加,当前钻探计划将2024年资源模型转换为测量和指示类别,并测试系统深部和侧向扩展[16][17] - 所有钻孔垂直钻入倾斜20 - 25度的钙质地层,多数钻孔穿过L1和L2矽卡岩/大理岩层及含铜浸染矿化的瓷土岩[18] - 2024年11月资源模型深度限于L1矽卡岩层底部,该层以下矿化截距可能扩展矿床深度,将纳入2026年第一季度资源模型更新[19] 质量控制 - 公司遵循严格质量保证/质量控制程序,包括插入空白样和标准样,钻孔岩芯运输至现场处理设施,样品送至ALS Canada分析[23] - 矿化间隔计算采用平均0.12%铜下限,真宽度估计为岩芯长度的90 - 92%[22] 铜当量计算 - 铜当量品位计算考虑金属品位、长期金属价格、回收率和净冶炼返回值[20] 信息披露 - 新闻稿科学技术内容由独立顾问审核、编制和批准[21] - 可访问公司网站获取钻孔位置图及更多信息,也可联系公司总裁咨询[27]
CLEAR to Provide Discounted TSA PreCheck® for Military Families
Globenewswire· 2025-07-10 18:00
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), an official TSA PreCheck® enrollment provider, is participating in the Transportation Security Administration’s (TSA) Serve with Honor, Travel with Ease initiative to provide discounted TSA PreCheck enrollment fees for military spouses and free enrollment for family members of service members who died in the line of duty or as a result of service-connected injury or illness–referred to as Gold Star families. A $25 enrollment discount will be app ...
Tri Pointe Homes Announces the Grand Opening of Altis at Serenity, Its First 55+ Lifestyle Brand Community on the East Coast in the Research Triangle Region
Globenewswire· 2025-07-10 18:00
With a New Home Gallery now open and sales underway, Altis at Serenity offers 55+ homebuyers a premium lifestyle neighborhood within the 550-acre Serenity planned community near the high-growth town of Fuquay-Varina Tri Pointe Homes® announced the grand opening of Altis at Serenity, its first 55+ lifestyle brand community on the East Coast, and its third Altis community nationwide. Located in North Carolina’s Research Triangle region, Altis at Serenity plans include exclusive resort-style amenities for it ...
Ontex listed on the 2024 CDP Supplier Engagement Leaderboard, recognizing its climate action efforts across the value chain
Globenewswire· 2025-07-10 16:59
Aalst, Belgium, July 10, 2025 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care solutions, is proud to have been recognized by CDP* for the second time in a row for its climate actions in partnership with its suppliers, specifically aimed at reducing its scope 3 emissions. Ontex is among the highest-rated companies that are celebrated in the 2024 Supplier Engagement Leaderboard, which evaluates corporate supply chain engagement on climate issues. Marco Qu ...
Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development
Globenewswire· 2025-07-10 16:00
文章核心观点 Rakovina Therapeutics公司公布其科学顾问委员会(SAB)阵容,该委员会由肿瘤学、人工智能驱动药物开发和精准医学领域的国际知名专家组成,能助力公司推进DDR管线迈向关键临床前和临床里程碑,公司也制定了未来的发展计划 [1][8] 公司介绍 - 公司是一家生物制药研究公司,专注开发创新癌症疗法,基于人工智能驱动的独特技术,利用专有平台审查和优化候选药物,已建立独特的DNA损伤反应抑制剂管线,目标是与制药合作伙伴合作推进候选药物进入人体临床试验 [12][13] 科学顾问委员会成员介绍 - Dr. Dennis Brown:SAB主席,有超35年癌症药物研发经验,是多家公司联合创始人,拥有40多项专利,曾任哈佛教员,现任Valent Technologies总裁和Mountain View Pharmaceuticals董事会主席 [2] - Dr. Artem Cherkasov:加拿大精准癌症药物设计研究主席,不列颠哥伦比亚大学教授和温哥华前列腺中心高级科学家,是Deep Docking™ AI平台先驱,该技术促成与罗氏1.42亿美元许可协议,支持公司AI驱动发现项目 [3] - Dr. Petra Hamerlik:曼彻斯特大学转化神经肿瘤学主席,曾在阿斯利康担任首席科学家和中枢神经系统癌症生物科学负责人,推进脑穿透性DNA损伤反应抑制剂开发 [4] - Dr. Leonard Post:有超35年制药研发领导经验,曾在多家公司任职,在PARP抑制剂talazoparib开发中发挥重要作用,现任Vivace Pharmaceuticals首席科学官 [5] - Dr. Neil Sankar:临床开发专家,在多家公司有领导经验,在Kadcyla和Ibrutinib的FDA申报中发挥重要作用,在国立癌症研究所接受培训,拥有班加罗尔大学医学博士学位 [6] - Dr. Wang Shen:公司KT - 2000和KT - 3000候选系列发明者,Viva Vision Biotech创始人兼CEO,FDA批准药物Lifitegrast的主要发明者和Venetoclax开发的关键贡献者,也是40多篇科学出版物和专利的共同作者 [7] 科学顾问委员会对公司战略的加速作用 - 快速AI到实验室验证:利用Dr. Cherkasov的Deep Docking™平台与UBC湿实验室集成,数月内验证成果 [8] - 转化专业知识:利用Dr. Hamerlik的中枢神经系统肿瘤学见解,优化脑穿透性DDR抑制剂 [8] - 临床开发领导:Dr. Sankar的监管和试验设计能力确保有效进入IND使能研究 [8] - 商业化途径:由Drs. Brown和Post丰富的许可和交易历史指导,构建高价值合作伙伴关系 [8] - 全球研发网络:利用委员会学术和行业联系,加速合作并扩大知识产权 [9] 公司未来计划 - 2025年下半年在领先行业会议上展示AI设计的DDR分子,展示下一代PARP1选择性和ATR抑制剂的体外和体内验证数据 [16] - 2025年7 - 10月优化当前管线,优化kt - 2000和kt - 5000系列的领先候选药物 [16] - 2025年第三季度展示ATR化合物中期疗效,分享ATR抑制剂的早期药理学和药代动力学数据 [16] - 2025年第三季度为kt - 3283建立开发合作,与领先公司合作开发适合临床开发的先进配方 [16] - 2025年第四季度至2026年第一季度继续为新型AI衍生的kt - 3000和kt - 2000系列候选药物进行合作讨论,利用AI驱动的临床前数据和战略SAB背书确保共同开发和许可合作伙伴关系 [16]
Share Buyback Transaction Details July 3 – July 9, 2025
Globenewswire· 2025-07-10 16:00
PRESS RELEASE Share Buyback Transaction Details July 3 – July 9, 2025 Alphen aan den Rijn – July 10, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 213,903 of its own ordinary shares in the period from July 3, 2025, up to and including July 9, 2025, for €29.6 million and at an average share price of €138.59. These repurchases are part of the share buyback program announced on February 26, 2025, under ...